Psychopharmacology and Pregnancy

Treatment Efficacy, Risks, and Guidelines

Psychopharmacology and Pregnancy

Treatment Efficacy, Risks, and Guidelines

128,39 €*

in Vorbereitung

This book examines the role of psychopharmacological treatment in a range of disorders that may be encountered during pregnancy, including major depressive disorders, anxiety disorders, bipolar affective disorder, schizophrenia, eating disorders and substance abuse. The natural history of each condition pre and post-partum is analyzed and the evidence for the efficacy of drug treatments, evaluated. Special attention is paid to the potential dangers of different treatment options for both mother and fetus, covering risks of malformation, pregnancy and obstetric risks, neonatal risks and possible long-term consequences. The risks of not treating a particular condition are also analyzed. On the basis of the available evidence, management guidelines are provided that additionally take into account non-pharmacological options. Closing chapters consider the value of complementary and alternative medicine and ECT and explore future research directions.

Introduction to Perinatal Psychiatry
The Process of Obtaining Informed Consent: Including Medico-legal implications
Methodology: How to Interpret the Literature and Level of Evidence
Physiological Changes in Pregnancy, the Biology of Exposure and Psychopharmacology
Outcomes for Mother and Child as a Result of Untreated Mental Illness
Major Depressive Disorders: Anti-depressants
Anxiety Disorders: Anxiolytics and Hypnotics
Bipolar Affective Disorder: Mood Stabilisers
Schizophrenia: Anti-Psychotics
Other Disorders: Eating Disorders, Borderline Personality Disorder
Substance Abuse Disorders
Complementary and alternative Medicines
ECT
Conclusion.
ISBN 9783642545610
Artikelnummer 9783642545610
Medientyp Buch
Auflage 2014
Copyrightjahr 2014
Verlag Springer, Berlin
Umfang 232 Seiten
Abbildungen VI, 232 p. 2 illus. in color.
Sprache Englisch